The dietary intervention has a primary role in the amelioration of NASH, whereas the combined supplementation of GEO and OCA with a healthy diet intervention demonstrated additional benefits through the inhibition of hepatic pro-inflammatory cytokines mediated through the NLRP3/ASC/caspase-1 pathways. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.